Business
Fri Nov 2,2018 10:00 am

Agatha Announces Reseller Agreement with Tri-I Biotech Shanghai Inc.

Agatha Inc.

Tokyo, Japan, November 1st, 2018 – Agatha Inc., a global leading provider of Quality and Content Management cloud service, Today announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc., a market leading China based consultancy providing high performance informatics solutions to over 1,000 medical and clinical research organizations across China, Hong Kong, Macau and Taiwan.

Tokyo, Japan, November 2nd, 2018 – Agatha Inc., a global leading provider of Quality and Content Management cloud service, Today announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc., a market leading China based consultancy providing high performance informatics solutions to over 1,000 medical and clinical research organizations across China, Hong Kong, Macau and Taiwan.

“We were looking for a partner who has a document management system specifically focused on hospitals and biotechnology companies, and offering a cloud-based service from China.” said Mr. Michael Lee, general manager at Tri-I Biotech Shanghai Inc. “It is essential that such a system supports both English and Chinese languages and meets the China market requirements in terms of regulatory compliance and data privacy. With Agatha cloud-based solution, we are confident to sell this first-class leading product in China to meet our customers’ demand to improve the management of their Quality and Clinical documentation and processes. This partnership will strengthen our position as a market leading solutions provider for Quality and Clinical systems in China.”

Tri-I works with medical research organizations including the top 50 clinical trial centers in China exclusively on their informatics and clinical data management projects, providing pre-purchase consulting and implementation services, which is the target market for Agatha Cloud service.

Agatha provides a comprehensive set of immediately available standard modules for Clinical Sites and Sponsors to manage and collaborate on their clinical documentation and processes.

“The partnership with Tri-I allows us to bring our market leading Quality and Clinical cloud solutions to research centers, biotechs and larger organizations across China, with implementation services and after sales support in Chinese language,” says Guillaume Gerard, Chief Operating Officer at Agatha. “Tri-I is experienced in implementing clinical solutions and related software systems and has entry into many of the top medical centers in China. We are very excited about this strategic partnership. It is an important step in Agatha further advancement into the Chinese market.”


[ABOUT Tri-I Biotech (Shanghai) Inc.]
Tri-I Biotech (Shanghai) Inc. was founded in May, 2008 at the White Cat Technical Park of Shanghai Jiaotong University.
Tri-I is dedicated to accelerating national development in the pharmaceutical and chemical industry by providing total solutions for biological research, pharmaceutical research, materials simulation, clinical test design, data analysis, information management and quality management. Tri-I keeps enlarging its services range, from HTS data analysis to biological knowledge mining, from systems biology based target identification to computer aided drug design, from ADMET prediction to clinical PK/PD research, and many other areas, to match the development issues of the national health and life sciences sector in China.
Tri-I has successfully supported and participated in many conferences and symposia in different areas of life sciences and materials science, and organized many intensive workshops and webinars, such as special course programs in molecular modeling and drug design, all geared towards training professionals in these important sectors, for the benefit of society.
Tri-I’s success relies heavily on its highly qualified staff and their seamless teamwork. Over 90% of Tri-I’s team members have a master’s degree or higher. For more information, visit http://tri-ibiotech.com.cn.

[About Agatha, Inc.]
Agatha, Inc. is a leading strategic software solutions provider to the health care and life sciences industry. Agatha is dedicated to helping the world’s Hospitals, biotechnology, pharmaceutical, contract research organizations and medical device firms optimize the management of their Quality and Clinical documentation and processes.
Agatha solutions are immediately available online, and compliant with applicable regulations (such as FDA 21 CFR part 11). Agatha’s clients are typically up and running in a few hours, and reduce the time spent to manage their clinical and quality documentation by 80%. Agatha is therefore the trusted partner of more than 100 hospitals, research centers, CROs, pharmaceutical companies and medical device companies worldwide. https://en.agathalife.com

[Contact]
Company: Agatha Inc.
Contact: Guillaume Gerard
Tel: +33 9 74 59 52 99
Email: info@agathalife.com